Delighted that the two-day Global Drug Regulatory Conclave 2026 commenced in Bharat Mandapam yesterday. As India's flagship international forum on pharmaceutical regulatory cooperation & convergence, the conclave brings together the heads and senior officials of national drug regulatory authorities from across the world. India seeks closer cooperation among the world's medicine regulators, supported by our expanding network of trade agreements. This will enable faster access to high-quality, affordable medicines for patients worldwide while strengthening India's position as a global hub for pharmaceutical innovation. Wishing the conclave great success in fostering deeper collaboration among the Indian pharmaceutical industry, global regulators, and stakeholders, paving the way for a more resilient, innovative, and patient-centric global healthcare ecosystem. Pharmexcil (Pharmaceuticals Export Promotion Council of India) Central Drugs Standard Control Organization Department of Commerce
Great to know about India’s ambition in this area. We would be happy to support Indian Pharma sector at www.inventicia.com with market entry support in Switzerland and EU leveraging the recent trade agreements